What does this research mean for the field?

Optical Genome Mapping (OGM) improves the diagnostic yield and precision of genetic testing in unsolved syndromic and neurogenetic disorders by detecting or refining structural variants missed by standard methods. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess the utility of optical genome mapping in resolving structural genetic variants and improving diagnostic accuracy for unsolved syndromic and neurogenetic diseases.

September 12, 2026Human GeneticsOpen Access

Optical genome mapping improves structural variant detection and characterization in syndromic and neurogenetic disorders

View Full Paper

Ask AI

Bookmark

Authors

RLRosa Catalina Lederbogen SHSabine Hoffjan CKCornelia Köhler

Discussion

Member takes

Overview

Diagnostic study reveals improved structural variant detection by optical genome mapping in neurogenetic disorders, highlighting enhanced diagnostic yield for complex chromosomal rearrangements.

Key Points

To assess the utility of optical genome mapping in resolving structural genetic variants and improving diagnostic accuracy for unsolved syndromic and neurogenetic diseases.
Applied optical genome mapping (OGM) to patients with neurogenetic and syndromic presentations previously evaluated by karyotyping, chromosomal microarray, or next-generation sequencing.
Analyzed structural aberrations including complex rearrangements, hereditary neuropathy cases (N=3), and ring chromosomes 18, 20, and 22 using an adjusted rare variant analysis pipeline.
OGM confirmed all previously known structural variants and provided refined diagnostic information in 6 of 10 syndromic cases, identifying a novel candidate gene and remapping translocation breakpoints.
Successfully detected and characterized ring chromosomes 18, 20, and 22 by adjusting filtering thresholds and applying a specialized rare variant pipeline.
Did not detect causative structural variants in 3 unsolved patients presenting with suspected hereditary neuropathy.

Cite This Study

Lederbogen et al. (2026) studied this question.

synapsesocial.com/papers/6aa51ebf327956e4761f892e https://doi.org/10.1007/s00439-026-02856-z

View Full Paper

Ask AI

Bookmark

September 12, 2026Human GeneticsOpen Access

Optical genome mapping improves structural variant detection and characterization in syndromic and neurogenetic disorders

View Full Paper

Ask AI

Bookmark

Authors

RLRosa Catalina Lederbogen SHSabine Hoffjan CKCornelia Köhler

Discussion

Member takes

Overview

Diagnostic study reveals improved structural variant detection by optical genome mapping in neurogenetic disorders, highlighting enhanced diagnostic yield for complex chromosomal rearrangements.

Key Points

To assess the utility of optical genome mapping in resolving structural genetic variants and improving diagnostic accuracy for unsolved syndromic and neurogenetic diseases.
Applied optical genome mapping (OGM) to patients with neurogenetic and syndromic presentations previously evaluated by karyotyping, chromosomal microarray, or next-generation sequencing.
Analyzed structural aberrations including complex rearrangements, hereditary neuropathy cases (N=3), and ring chromosomes 18, 20, and 22 using an adjusted rare variant analysis pipeline.
OGM confirmed all previously known structural variants and provided refined diagnostic information in 6 of 10 syndromic cases, identifying a novel candidate gene and remapping translocation breakpoints.
Successfully detected and characterized ring chromosomes 18, 20, and 22 by adjusting filtering thresholds and applying a specialized rare variant pipeline.
Did not detect causative structural variants in 3 unsolved patients presenting with suspected hereditary neuropathy.

Cite This Study

Lederbogen et al. (2026) studied this question.

synapsesocial.com/papers/6aa51ebf327956e4761f892e https://doi.org/10.1007/s00439-026-02856-z

View Full Paper

Ask AI

Bookmark